GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (BOM:543635) » Definitions » PB Ratio

Piramal Pharma (BOM:543635) PB Ratio : 2.50 (As of May. 30, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-30), Piramal Pharma's share price is ₹149.95. Piramal Pharma's Book Value per Share for the quarter that ended in Mar. 2024 was ₹60.03. Hence, Piramal Pharma's PB Ratio of today is 2.50.

The historical rank and industry rank for Piramal Pharma's PB Ratio or its related term are showing as below:

BOM:543635' s PB Ratio Range Over the Past 10 Years
Min: 1.2   Med: 2.09   Max: 3.08
Current: 2.46

During the past 4 years, Piramal Pharma's highest PB Ratio was 3.08. The lowest was 1.20. And the median was 2.09.

BOM:543635's PB Ratio is ranked worse than
60.17% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.945 vs BOM:543635: 2.46

During the past 12 months, Piramal Pharma's average Book Value Per Share Growth Rate was 7.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 21.20% per year.

During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Piramal Pharma was 21.20% per year. The lowest was 21.20% per year. And the median was 21.20% per year.

Back to Basics: PB Ratio


Piramal Pharma PB Ratio Historical Data

The historical data trend for Piramal Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma PB Ratio Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
PB Ratio
- - 1.20 2.15

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 - 1.73 - 2.15

Competitive Comparison of Piramal Pharma's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Piramal Pharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's PB Ratio falls into.



Piramal Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Piramal Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=149.95/60.025
=2.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Piramal Pharma  (BOM:543635) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Piramal Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Piramal Pharma (BOM:543635) Business Description

Traded in Other Exchanges
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (BOM:543635) Headlines

No Headlines